Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastoma Multiforme of the Brain”

358 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 358 results

Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01290692
What this trial is testing

Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma

Who this might be right for
Grade IV GliomaGrade IV AstrocytomaGlioblastoma Multiforme
TVAX Biomedical 14
Early research (Phase 1)Study completedNCT00509301
What this trial is testing

Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Glioblastoma Multiforme
Peregrine Pharmaceuticals 12
Early research (Phase 1)Study completedNCT00002753
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Duke University 6
Not applicableStudy completedNCT05383872
What this trial is testing

Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors

Who this might be right for
GlioblastomaGliomaLiquid Biopsy
InSightec 71
Testing effectiveness (Phase 2)Looking for participantsNCT07462507
What this trial is testing

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

Who this might be right for
Central Nervous System CancerBrain Metastases
Washington University School of Medicine 104
Not applicableActive Not RecruitingNCT06649591
What this trial is testing

Expert Consensus and Artificial Intelligence in Medical Decision Making in Patients with Malignant Brain Tumors

Who this might be right for
Malignant Brain Tumors
Tufts Medical Center 225
Early research (Phase 1)Ended earlyNCT06193174
What this trial is testing

Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)

Who this might be right for
Recurrent Malignant GliomaGlioblastoma Multiforme of BrainGliosarcoma of Brain+1 more
University of Alabama at Birmingham 1
Testing effectiveness (Phase 2)Study completedNCT00004017
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Peregrine Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT01019434
What this trial is testing

Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 111
Not applicableUnknownNCT01798771
What this trial is testing

Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery

Who this might be right for
Primary Malignant Neoplasm of Nervous SystemGliomaGlioblastoma+1 more
Johann Wolfgang Goethe University Hospital 108
Testing effectiveness (Phase 2)Study completedNCT00004200
What this trial is testing

Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Early research (Phase 1)Temporarily pausedNCT04222309
What this trial is testing

Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

Who this might be right for
GliomaGlioma, MalignantGlioblastoma+4 more
Northwell Health 10
Testing effectiveness (Phase 2)UnknownNCT03294486
What this trial is testing

Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients

Who this might be right for
GlioblastomaBrain Cancer
Assistance Publique - Hôpitaux de Paris 78
Testing effectiveness (Phase 2)Study completedNCT02474966
What this trial is testing

Effect of Deep TMS on the Permeability of the BBB in Patients With Glioblastoma Multiforme: a Pilot Study

Who this might be right for
Glioblastoma Multiforme of Brain
University of Roma La Sapienza 15
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Not applicableAvailableNCT02146066
What this trial is testing

Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

Who this might be right for
GBMGlioblastoma Multiforme
Northwest Biotherapeutics
Not applicableUnknownNCT01317888
What this trial is testing

Access Protocol for MAB-425 Radiolabeled With I-125 for High Grade Gliomas

Who this might be right for
Glioblastoma MultiformeAstrocytoma Anaplastic Foci
Drexel University 11
Early research (Phase 1)Study completedNCT00036894
What this trial is testing

CC-5013 in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT00376103
What this trial is testing

Radiation Boost for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Methodist Healthcare - Memphis 3
Next Page